Responses
Immunotherapy biomarkers
Original research
Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.